Skye Bioscience
SKYE
#10994
Rank
NZ$12.63 M
Marketcap
NZ$2.85
Share price
-0.62%
Change (1 day)
-61.00%
Change (1 year)

Earnings for Skye Bioscience (SKYE)

Earnings in 2026 (TTM): -NZ$87.67 Million

According to Skye Bioscience's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$99.73 Million a decrease over its 2024 earnings that were of -NZ$55.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Skye Bioscience from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$87.67 Million-12.1%
2025 -NZ$99.73 Million78.42%
2024 -NZ$55.9 Million-14.65%
2023 -NZ$65.5 Million95.21%
2022 -NZ$33.55 Million142.64%
2021 -NZ$13.83 Million32.46%
2020 -NZ$10.44 Million-388.11%
2019 NZ$3.62 M-110.64%
2018 -NZ$34.07 Million611.81%
2017 -NZ$4.79 Million-39.99%
2016 -NZ$7.98 Million3.55%
2015 -NZ$7.7 Million68.42%
2014 -NZ$4.58 Million-123633.06%
2013 NZ$0 M-58.76%
2012 NZ$0 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.28 Billion 209.28%๐Ÿ‡บ๐Ÿ‡ธ USA